Advisory Research
CVS icon

Advisory Research’s CVS Health CVS Stock Holding History

Advisory Research’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.4M Buy
+144,670
New +$14.2M 1.31% 26
2018
Q1 		– Sell
-328,177
Closed -$23.8M – 385
2017
Q4 		$23.8M Sell
328,177
-105,272
-24% -$7.65M 0.39% 71
2017
Q3 		$35.2M Buy
433,449
+184,076
+74% +$14.6M 0.56% 55
2017
Q2 		$20.1M Buy
249,373
+205,816
+473% +$16.3M 0.32% 83
2017
Q1 		$3.42M Sell
43,557
-17,160
-28% -$1.37M 0.05% 197
2016
Q4 		$4.79M Sell
60,717
-1,350
-2% -$109K 0.07% 130
2016
Q3 		$5.52M Buy
62,067
+8,124
+15% +$767K 0.09% 114
2016
Q2 		$5.16M Sell
53,943
-17,188
-24% -$1.71M 0.09% 115
2016
Q1 		$7.38M Sell
71,131
-115,270
-62% -$11.2M 0.14% 108
2015
Q4 		$18.2M Sell
186,401
-5,601
-3% -$549K 0.28% 98
2015
Q3 		$18.5M Sell
192,002
-3,401
-2% -$358K 0.26% 102
2015
Q2 		$20.5M Buy
195,403
+33,061
+20% +$3.38M 0.23% 110
2015
Q1 		$16.8M Buy
+162,342
New +$16.4M 0.18% 116
2014
Q2 		– Sell
-942
Closed -$71K – 409
2014
Q1 		$71K Buy
+942
New +$66.5K ﹤0.01% 450

Other funds holding CVS

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Davis Selected Advisers
Davis Selected Advisers Tucson, Arizona $23.2B AUM 18.42% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Advisory Research's CVS Position: Q3 2026 in Review

Advisory Research opened a new position in CVS Health (CVS) in Q3 2026: 144,670 shares worth $12.4M. The stake represents 1.31% of the portfolio and ranks #26 among its holdings. This is a return to the name: Advisory Research previously reported a position in CVS as recently as Q4 2017.

Advisory Research first reported a position in CVS in Q1 2014 and has held it in 14 quarters since. The position peaked at $35.2M in Q3 2017. 1,540 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Advisory Research held 144,670 shares of CVS Health worth $12.4M as of Q3 2026.
  • CVS Health was a new Advisory Research position in Q3 2026.
  • CVS Health made up 1.31% of Advisory Research's portfolio in Q3 2026, its #26 holding.
  • Advisory Research first reported a position in CVS Health in Q1 2014 and has held it in 14 quarters since.
  • Advisory Research's CVS Health position peaked at $35.2M in Q3 2017.
  • 1,540 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Advisory Research's 13F filing for Q3 2026, filed 12 Nov 2026.